Page 244 - HIV/AIDS Guidelines

a
Appendix C, Table 1. Monthly Average Wholesale Price of Antiretroviral Drugs (Last updated March
27, 2012; last reviewed March 27, 2012) (page 2 of 2)

Antiretroviral Drug Strength Dosing Tabs/Capsules/ AWP a
Generic (Brand) Name mLs per Month (Monthly)
saquinavir (Invirase) 500-mg tab b 2 tabs twice daily 120 tabs $1,088.84

tipranavir (Aptivus) 250-mg cap b 2 caps twice daily 120 caps $1,335.14
Integrase Strand Transfer Inhibitor (INSTI)

raltegravir (Isentress) 400-mg tab 1 tab twice daily 60 tabs $1,171.30
Fusion Inhibitor
enfuviritide (Fuzeon) 90-mg inj kit 1 inj twice daily 60 doses $3,248.72
(1 kit)
CCR5 Antagonist
maraviroc (Selzentry) 150-mg tab 1 tab twice daily 60 tabs $1,148.16
300-mg tab 1 tab twice daily 60 tabs $1,148.16
Coformulated Combination Antiretroviral Drugs

abacavir/lamivudine (Epzicom) 600/300-mg tab 1 tab daily 30 tabs $1,118.90

tenofovir/emtricitabine (Truvada) 300/150-mg tab 1 tab daily 30 tabs $1,391.45

zidovudine/lamivudine (generic) 300/150-mg tab 1 tab twice daily 60 tabs $931.61
(Combivir) 300/150-mg tab 1 tab twice daily 60 tabs $1,035.12

abacavir/lamivudine/zidovudine 600/150/300-mg tab 1 tab twice daily 60 tabs $1,676.62
(Trizivir)

lopinavir/ritonavir (Kaletra) 200 mg/50-mg tab 2 tabs twice daily or 120 tabs $871.36
400 mg/100 mg per 4 tabs once daily 300 mL $871.34
5-mL soln 5 mL twice daily
rilpivirine/tenofovir/emtricitabine 200/25/300 mg 1 tab daily 30 tabs $2,195.83
(Complera)
efavirenz/tenofovir/emtricitabine 300/200/600 mg 1 tab daily 30 tabs $2,080.97
(Atripla)

a AWP = Average Wholesale Price in 2012 (source: First DataBank Blue Book AWP, accessed January 2012) Note that this price may not
represent the pharmacy acquisition price or the price paid by consumers.
b Should be used in combination with ritonavir. Please refer to Appendix B, Table 3 for ritonavir doses.
Key to Abbreviations: AWP = average wholesale price; cap = capsule, DR = delayed release, EC = enteric coated, inj = injection,
soln = solution, tab = tablet, XR = extended release

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents P-2

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.